Mount Sinai Innovation Partners (MSIP), the commercialization engine of the Mount Sinai Health System (Mount Sinai) in New York City, has launched Elementa Labs, a virtual incubator program that aims to position health care and biotechnology startup companies for the next stage in their development.
The program empowers companies to strategically align with Mount Sinai, gaining access to subject matter experts in health care and the potential to advance their core technology platforms. Participating companies will work directly with a Mount Sinai champion who will facilitate navigation within the Health System and enable access to key stakeholders, resources, and know-how to advance product development.
"Elementa Labs will integrate Mount Sinai's research and clinical expertise with the business and product development infrastructure of health care startup companies," said Erik Lium, PhD, President of MSIP and Chief Commercial Innovation Officer of Mount Sinai Health System. "We look forward to engaging with entrepreneurs to bring health care innovations to the patient population."
The first member of Elementa's inaugural cohort is digital health company avoMD, which has launched a next-generation platform providing decision support for clinicians. The company will work with Mount Sinai to create a strategic path to conduct research, further validate studies, and surface the depth of clinical needs for their platform at a leading health care system.
"We are thrilled by the opportunity to enhance our platform and offerings by working with Mount Sinai, a global leader in education, cutting-edge research and innovation, and high-quality care," said Laurence Coman, Chief Operating Officer and Co-Founder of avoMD. "Elementa Labs will help take avoMD to the next level."
